Ionis Pharmaceuticals (IONS) revenue

Revenue · fiscal 2025
$943.71M

Ionis Pharmaceuticals (IONS) reported revenue of $943.71M in fiscal 2025 (the year ended December 31, 2025). That is 33.8% higher than the $705.14M of fiscal 2024. Figures as of 18 Nov 2026, 07:55 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$943.71M
Change on fiscal 2024
+33.8%
Growth, 5 years
+5.3% a year
Growth, 10 years
+12.8% a year
Highest on record
$1.12Bfiscal 2019
Lowest on record
$99.09Mfiscal 2011
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Ionis Pharmaceuticals revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 5.3% a year; over ten years the rate was 12.8% a year. Across the 18 fiscal years on record (2008–2025), the highest was $1.12B in fiscal 2019 and the lowest $99.09M in fiscal 2011.

History · 18 fiscal years

Revenue by fiscal year

Ionis Pharmaceuticals revenue, year by year

Ionis Pharmaceuticals (IONS) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$943.71M 33.8% up
2024$705.14M 10.5% down
2023$787.65M 34.1% up
2022$587.37M 27.5% down
2021$810.46M 11.1% up
2020$729.26M 35.0% down
2019$1.12B 87.2% up
2018$599.67M 16.6% up
2017$514.18M 37.9% up
2016$372.78M 31.4% up
2015$283.70M 32.5% up
2014$214.16M 45.4% up
2013$147.29M 44.3% up
2012$102.05M 3.0% up
2011$99.09M 8.7% down
2010$108.47M 10.8% down
2009$121.60M 13.4% up
2008$107.19M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Ionis Pharmaceuticals and comparable companies
CompanyRevenueFiscal year
LivaNova LIVN$1.39B2025
Ionis Pharmaceuticals IONS$943.71M2025
Dianthus Therapeutics DNTH$2.04M2025
MiniMed Group MMED$3.10B2026
Adaptive Biotechnologies ADPT$276.98M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on IONS

Ionis Pharmaceuticals, figure by figure

Ionis Pharmaceuticals (IONS) overview: price, valuation and scorecardAll health care companies by market value

Ionis Pharmaceuticals revenue: questions and answers

What is Ionis Pharmaceuticals's revenue?

Ionis Pharmaceuticals (IONS) reported revenue of $943.71M in fiscal 2025 (the year ended December 31, 2025). That is 33.8% higher than the $705.14M of fiscal 2024.

What is the growth rate of Ionis Pharmaceuticals's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 5.3% a year; over ten years the rate was 12.8% a year.

What are the highest and lowest revenue figures on record for Ionis Pharmaceuticals?

Across the 18 fiscal years on record (2008–2025), the highest was $1.12B in fiscal 2019 and the lowest $99.09M in fiscal 2011.

How is Ionis Pharmaceuticals's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ionis Pharmaceuticals (IONS) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/IONS/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.